128 related articles for article (PubMed ID: 20479591)
1. A case of advanced non-Hodgkin's lymphoma involving the prostate: staging and treatment monitoring using F-18 FDG PET/CT imaging.
Cimarelli S; Lachenal F; Ricard F; Chassagne-Clément C; Heudel PE; Janody P; Sebban C
Clin Nucl Med; 2010 Jun; 35(6):425-7. PubMed ID: 20479591
[No Abstract] [Full Text] [Related]
2. The role of PET in lymphoma.
Jhanwar YS; Straus DJ
J Nucl Med; 2006 Aug; 47(8):1326-34. PubMed ID: 16883013
[TBL] [Abstract][Full Text] [Related]
3. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
4. Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease.
Jerusalem G; Beguin Y; Fassotte MF; Najjar F; Paulus P; Rigo P; Fillet G
Haematologica; 2001 Mar; 86(3):266-73. PubMed ID: 11255273
[TBL] [Abstract][Full Text] [Related]
5. FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease.
Querellou S; Valette F; Bodet-Milin C; Oudoux A; Carlier T; Harousseau JL; Chatal JF; Couturier O
Ann Hematol; 2006 Nov; 85(11):759-67. PubMed ID: 16871391
[TBL] [Abstract][Full Text] [Related]
6. Interesting image. Incidental diagnosis of prostate cancer by F-18 FDG PET/CT.
Monet A; Merino B; Lupo R
Clin Nucl Med; 2010 Jan; 35(1):34-5. PubMed ID: 20026972
[No Abstract] [Full Text] [Related]
7. Non-Hodgkin's lymphoma of the bone and the liver without lymphadenopathy revealed on FDG-PET/CT.
Cheng G; Servaes S; Chamroonrat W; Li J; Zhuang H
Clin Imaging; 2010; 34(6):476-9. PubMed ID: 21092880
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced pneumonitis detected earlier by 18F-FDG-PET than by high-resolution CT: a case report with non-Hodgkin's lymphoma.
Yamane T; Daimaru O; Ito S; Nagata T; Yoshiya K; Fukaya N; Ito S; Imai T; Uchida H
Ann Nucl Med; 2008 Oct; 22(8):719-22. PubMed ID: 18982476
[TBL] [Abstract][Full Text] [Related]
9. Spinal cord involvement secondary to non-Hodgkin's lymphoma identified by ¹⁸F-FDG PET/CT.
Mapelli P; Vanoli EG; Picchio M; Gianolli L
Rev Esp Med Nucl Imagen Mol; 2013 Mar; 32(2):125. PubMed ID: 23246137
[No Abstract] [Full Text] [Related]
10. PET/CT for therapy response assessment in lymphoma.
Hutchings M; Barrington SF
J Nucl Med; 2009 May; 50 Suppl 1():21S-30S. PubMed ID: 19380407
[TBL] [Abstract][Full Text] [Related]
11. Use of 18F-FDG positron emission tomography following allogeneic transplantation to guide adoptive immunotherapy with donor lymphocyte infusions.
Hart DP; Avivi I; Thomson KJ; Peggs KS; Morris EC; Goldstone AH; Linch DC; Ell PJ; Bomanji JB; Mackinnon S
Br J Haematol; 2005 Mar; 128(6):824-9. PubMed ID: 15755287
[TBL] [Abstract][Full Text] [Related]
12. Intraocular lymphoma and central nervous system lymphoma involving the hypothalamus: staging and evaluation of response to therapy with F-18 FDG PET/CT.
Makis W; Novales-Diaz JA; Hickeson M
Clin Nucl Med; 2010 Dec; 35(12):956-9. PubMed ID: 21206231
[No Abstract] [Full Text] [Related]
13. Giant cardiac tumour thrombus on staging contrast enhanced ¹⁸F-FDG PET/CT in a case of non-Hodgkin's lymphoma.
Jeph S; Thakur K; Shamim SA; Verma K; Aggarwal B; Aggarwal A
Rev Esp Med Nucl Imagen Mol; 2014; 33(5):328-9. PubMed ID: 24618093
[No Abstract] [Full Text] [Related]
14. Imaging of non-Hodgkin lymphomas: diagnosis and response-adapted strategies.
El-Galaly TC; Hutchings M
Cancer Treat Res; 2015; 165():125-46. PubMed ID: 25655608
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune lymphoproliferative syndrome and non-Hodgkin lymphoma: what 18F-fluorodeoxyglucose positron emission tomography/computed tomography can do in the management of these patients? Suggestions from a case report.
Cistaro A; Pazè F; Durando S; Cogoni M; Faletti R; Vesco S; Vallero S; Quartuccio N; Treglia G; Ramenghi U
Rev Esp Med Nucl Imagen Mol; 2014; 33(2):99-102. PubMed ID: 23845452
[TBL] [Abstract][Full Text] [Related]
16. The role of PET/computed tomography scan in the management of prostate cancer.
Picchio M; Giovannini E; Messa C
Curr Opin Urol; 2011 May; 21(3):230-6. PubMed ID: 21378572
[TBL] [Abstract][Full Text] [Related]
17. Hodgkin's and non-Hodgkin's lymphomas.
Rademaker J
Radiol Clin North Am; 2007 Jan; 45(1):69-83. PubMed ID: 17157624
[TBL] [Abstract][Full Text] [Related]
18. Diffuse skeletal muscle F-18 fluorodeoxyglucose uptake in advanced primary muscle non-Hodgkin's lymphoma.
Broski SM; Bou-Assaly W; Gross MD; Fig LM
Clin Nucl Med; 2009 Apr; 34(4):251-3. PubMed ID: 19300063
[TBL] [Abstract][Full Text] [Related]
19. Stage IE non-Hodgkin's thyroid lymphoma on (18)F-FDG-PET/CT.
Mehta A; Muthukrishnan A
Hell J Nucl Med; 2011; 14(2):186-7. PubMed ID: 21761029
[No Abstract] [Full Text] [Related]
20. Commentary: PET poised to alter the current paradigm for response assessment of non-Hodgkin's lymphoma.
Guermazi A; Juweid ME
Br J Radiol; 2006 May; 79(941):365-7. PubMed ID: 16632614
[No Abstract] [Full Text] [Related]
[Next] [New Search]
